Skip to main content
. 2019 Aug 13;13:2827–2832. doi: 10.2147/DDDT.S215927

Table 6.

The serum levels of cTnI and CysC

cTnI(\bix±s ng/L) CysC (\bix±s mg/L)
Pre-treatment 24 hrs after treatment 48 hrs after treatment Pretreatment 24 hrs after treatment 48 hrs after treatment
Normal (n=8) 98.45±84.76 0.84±0.08
Group A (n=11) 423.19±240.53* 218.34±76.38 106.12±51.41Δ# 3.87±0.69* 2.06±0.28 1.17±0.42Δ#
Group B (n=12) 407.38±263.27* 237.42±85.36 125.16±53.25# 3.56±0.35* 2.38±0.42 1.45±0.44#
Group C (n=12) 416.15±252.23* 314.81±90.32 184.57±64.37 3.71±0.71* 2.87±0.54 1.98±0.61

Notes: cTnI treatment factor main effects, F=43.1, P<0.01, time factor main effect, F=30.26, P<0.01, interaction between the two, F=14.41, P<0.01; CysC treatment factor main effects, F=7.16, P<0.01, time factor main effect, F=173.77, P<0.01, interaction between the two, F=5.81, P<0.01; *P<0.01 vs normal, ΔP<0.05 vs group B, #P<0.01 vs group C.

Abbreviations: cTnI, cardiac troponinI; CysC, cystatin C.